La Jolla Pharmaceutical Company Receives Orphan Designation From FDA

SAN DIEGO, CA--(Healthcare Sales & Marketing Network) - La Jolla Pharmaceutical Company (OTCBB: LJPC) ("La Jolla" and "Company"), a leader in the development of therapeutics targeting life threating diseases, announced today that the FD... Biopharmaceuticals, Neurology, FDALa Jolla Pharmaceutical, LJPC-0712, Niemann-Pick
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news